Capital Guardian Trust’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Capital Guardian Trust’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-24	Closed	-$1K	–	841
2016 Q1	$1K	Buy	+24	New	+$1.77K	﹤0.01%	794

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Capital Guardian Trust's ANAC Position: Q2 2016 in Review

Capital Guardian Trust sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 24 shares — an estimated $1K sold.

Capital Guardian Trust first reported a position in ANAC in Q1 2016 and held it in 1 quarter. The position peaked at $1K in Q1 2016. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Capital Guardian Trust reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Capital Guardian Trust sold 24 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $1K.
Capital Guardian Trust first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2016 and held it in 1 quarter.
Capital Guardian Trust's ANACOR PHARMACEUTICALS INC COM position peaked at $1K in Q1 2016.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Capital Guardian Trust's 13F filing for Q2 2016, filed 15 Aug 2016.